Skip to main content
Clinical Trials/NCT04029142
NCT04029142
Completed
Not Applicable

Screening for Hemoglobinopathies in Pregnant Women

University Hospital, Basel, Switzerland1 site in 1 country1,785 target enrollmentJuly 3, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemoglobinopathies
Sponsor
University Hospital, Basel, Switzerland
Enrollment
1785
Locations
1
Primary Endpoint
identification of hemoglobinopathies
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This prospective monocentric study project is to identify hemoglobinopathies in pregnant women in order to optimize antenatal care and to investigate the prevalence of hemoglobinopathies in pregnant women in Switzerland.

Registry
clinicaltrials.gov
Start Date
July 3, 2019
End Date
September 30, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pregnant women seen at the Frauenklinik at University Hospital Basel

Exclusion Criteria

  • pregnant women with already known hemoglobinopathy
  • refusal of participation

Outcomes

Primary Outcomes

identification of hemoglobinopathies

Time Frame: single time point assessment at baseline

identification of hemoglobinopathies by investigating routine lab samples

Study Sites (1)

Loading locations...

Similar Trials